tirzepatide vials B12/B6 Vial Prescription tirzepatide from now available from Weightcare Tirzepatide | GLP1 | Medical

Its structure has been changed to make it more stable and help it connect with receptors better

Tirzepatide has a half-life of about five days, which allows it to be taken once per week

This medication has been clinically proven to help adults achieve significant weight loss by using both injection and oral formulations

Patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should not use GLP-1 medications due to a theoretical risk of thyroid tumors observed in animal studies

Regulatory approval in Canada falls under Health Canada, which oversees both pharmaceutical and compounded preparations

Teredesai A., Wohrmann T., Schlage W